secwatch.observer — SEC 8-K summary
======================================

Issuer:     INVO Fertility, Inc. (IVF)
CIK:        0001417926
Form:       8-K
Filed at:   2023-07-27T23:59:59+00:00
Accession:  0001493152-23-025720
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INVO Bioscience 1-for-20 reverse stock split effective July 28; Nasdaq panel grants continued listing until Sept 29
--------------------------------------------------------------------------------

- Reverse split every 20 shares into 1; effective 12:01 a.m. ET July 28, 2023; trading symbol unchanged (INVO).
- Post-split shares outstanding ~842,017; authorized shares reduced to 6,250,000; fractional shares rounded up.
- Nasdaq Hearings Panel granted continued listing subject to compliance with $1.00 bid price and $2.5M equity by Sept 29, 2023.
- Reverse split intended to regain Nasdaq minimum bid price compliance; no assurance of success.
- Company previously non-compliant with bid price and equity requirements; July 6 hearing discussed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417926/000149315223025720/0001493152-23-025720-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417926/000149315223025720/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-025720

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer